HappyNeuron is proud to support an international community of researchers and participate in the pursuit of understanding cognitive rehabilitation. We’ve partnered with and continue to partner with independent research teams who are pushing the knowledge boundaries of how cognitive rehabilitation applies to specific populations, medical conditions, or outcomes. Within the last 20 years, we have partnered with many research institutions on five different continents in many different languages.
We support research by providing access to our tools at a heavily discounted (or even waived) cost, creating custom services, or facilitating access to data collection. We do not impose any constraints to protocols or hypothesis, and provide all the assistance we can to best fit in any clinical trial.
We are always open to new collaborative opportunities! Get in touch with us anytime for more information on how HappyNeuron can support your research.
The Centre for Addiction and Mental Health in Toronto, ON, Canada, is Canada’s largest mental health teaching hospital and one of the world’s leading research centres.
It is running several clinical trials including HappyNeuron Pro tools to investigate the effects and value of cognitive remediation for different purposes: Preventing Alzheimer’s desease along with tDCS, exploring remediation for Schizophrenic or Bipolar patients with Psychosis or other Mental Health issues.
The Icahn School of Medicine at Mount Sinai leads the US in clinical neuroscience research with funding from the National Institutes of Health.
In collaboration with a New York VA hospital, researchers are investigating how computerized cognitive training (CCT) can help improve cognitive control and decision-making/problem-solving for veterans suffering from major depressive disorder (MDD) with suicidal ideation.
Boehringer Ingelheim is one of the world’s largest pharmaceutical companies, and the largest private one.
HappyNeuron has been chosen to provide the at-home computerized cognitive training for inclusion in an international multicentric clinical trial that investigates the efficacy of a potential new treatment. This ongoing trial compares the effect of a drug on cognition in patients with schizophrenia on a background of stable antipsychotic treatment and of at-home computerized cognitive training.
For the first time, an at-home cognitive training is added to the scientific design in the framework of a large international clinical trial in the CNS field.
Le Vinatier is a Psychiatric Hospital in Lyon, France, that is a reference in the country.
HappyNeuron has been collaborating closely with this insitution for years to create several new programs targeting social cognition for different populations.
Dr. David Castle, Dr. Andrea Phillipou, Dr. Gaye Moore, Caroline Crosse AM, Anne Miles OT have conducted a research study on the effects of vocational rehabilitation for persons battling severe mental illness.
Cognitive remediation therapy services in conjunction with hands-on work experience have been investigated to learn ways to help people with mental illness not succumb to unemployment and be able to live more independent lives.